| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 |
| filingDate |
2013-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2021-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-102202808-B1 |
| titleOfInvention |
Medical patch |
| abstract |
An object is to provide a medical patch that contains a large amount of a drug or a dissolution aid and forms an adhesive layer that is flexible and has excellent release of the drug from the adhesive layer without any shape destruction or adhesive. Copolymerization with a drug having a secondary or tertiary amine structure in the molecule, a liquid preparation for pharmaceuticals, and a monomer of (meth)acrylic acid ester as a main component of the monomer, and a functional group capable of forming a crosslink by reacting with a crosslinking agent having an isocyanate group It is a medical patch comprising a resin composition in which an acrylic resin is crosslinked with a crosslinking agent having an isocyanate group blocked, and has a solubility of 0.5% by weight or more in a phosphate buffer (pH6.4) of the drug. |
| priorityDate |
2012-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |